All Episodes
Oncotarget — 500 episodes · page 3 of 5
Leveraging Gold Nanostars for Precision Laser Interstitial Thermal Therapy
Impact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast Cancer
Assessment of CEA, CA-125, and CA19-9 as Adjuncts in Non-small Cell Lung Cancer Management
When Does a Melanoma Metastasize? Implications for Management
Impact Journals Sponsors 2024 Ride for Roswell
Dr. Blagosklonny’s Strategy: From Osimertinib to Preemptive Combinations
Synergistic Cytotoxicity of HDAC and PARP Inhibitors and Decitabine in Pancreatic Cancer Cells
BTK Inhibitor-related Cardiotoxicity: Quest for Predictive Biomarkers, Improved Risk Stratification
Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167
The Importance of Integrated Therapies on Cancer: Silibinin, an Old and New Molecule
Combating Doxorubicin-Resistant Acute Myeloid Leukemia
GZ17-6.02 Kills Uveal Melanoma Cells
Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 via EMT and Antiviral Immune Response
Expression of Cyclin D1 in Penile Cancer
Oncotarget at SSP 46th Annual Meeting
SARS-CoV-2 Spike Protein Disrupts p53 Tumor Suppressor Pathway
Deep Learning-based Whole-body Prostate-specific Membrane Antigen PET/CT Attenuation Correction
Transfected SARS-CoV-2 Spike DNA Suppresses Cancer Cell Response to Chemotherapy
Oncotarget Sponsors 19th International p53 Workshop in Italy
Novel Therapeutic Bispecific Antibodies for B-cell Lymphoma
Synergistic Effects of Drug Combinations Targeting AML Cells
Exploring the Role of MIA-602 in Overcoming Doxorubicin-resistance in Acute Myeloid Leukemia
Identifying Biomarkers for Predicting Paclitaxel Response
Durvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast Cancer
ABT199/Venetoclax Synergism With Thiotepa in Acute Myeloid Leukemia (AML) Cells
Analytical Validation of an Ultra-sensitive Personalized Circulating Tumor DNA Assay: NeXT Personal®
“From Osimertinib to Preemptive Combinations” by Dr. Blagosklonny
A New Antibody Capture Method Reveals G-quadruplex Landscape and its Regulation
Antitumor Effects of Sacituzumab Govitecan Plus Platinum-Based Chemotherapy
Oncotarget at AACR Annual Meeting 2024
GZ17-6.02 With Proteasome Inhibitors Kills Multiple Myeloma Cells
Sacituzumab Govitecan Plus Platinum-based Chemotherapy in Breast, Bladder, and Lung Carcinomas
BRCA1 and BRCA2 in a Cohort of Ovarian Cancer Patients From the Salento Peninsula
GZ17-6.02 With Bexarotene Kills Mycosis Fungoides Cells
Raw Areca Nut Betel Quid Consumption and Esophageal Cancer
Combining Causal and Correlative Approaches to Discover Response Biomarkers to Paclitaxel
NTRK Gene Fusion in Thyroid Cancer: A Clinicogenomic Biobank and Record Linkage Study From Finland
Oncotarget’s Top 10 Papers Published in 2023 (Crossref Data)
Genetic and Therapeutic Landscapes in Cohort of Pancreatic Cancer Using NGS and Machine Learning
Differential Expression of Mad2 Gene in Human Esophageal Cancer
Genetic Alterations in Thyroid Cancer: Resistance to BRAFi and Anaplastic Transformation
Evaluation of Ruxolitinib, a Janus Kinase Inhibitor, in Multiple Myeloma
Drug Discovery in Academia; Dumping in the Publication Landfill?
BCAS1 Defines a Heterogeneous Cell Population in Diffuse Glioma Patients
Gene Alterations in Thyroid Cancer Mediate Resistance to BRAF Inhibition & Anaplastic Transformation
New Drug May Boost Effectiveness of Glioblastoma Treatment
Lazarus Effect in Patient Treated with Osimertinib for NSCLC with Leptomeningeal Disease
Published in Oncoscience: My Battle with Cancer. Part 1.
Bone Marrow Adipocytes Provide Early Sign of Progression from MGUS to Multiple Myeloma
ATR Inhibition Using Gartisertib in Patient-derived Glioblastoma Cell Lines
Reductive Carboxylation of Glutamine as a Potential Target in AML
How Osteopontin Stimulates Mitochondrial Biogenesis and Cancer Metastasis
One More Step Toward Treatment of PARP Inhibitor-resistant Ovarian Cancers
Transformation-associated Recombination (TAR) Cloning and Its Applications
Therapeutically Harnessing Cancer Stem Cell-derived Exosomes
Melatonin in Cancer Therapy: Lessons From 50 Years of Research
GFH009: A Potent and Highly Selective CDK9 Inhibitor for the Treatment of Hematologic Malignancies
Management of Refractory or Relapsed Classic Hodgkin Lymphoma in Brazil
Melatonin and Carcinogenesis in Mice
Triple Combination Treatment Overcomes Colorectal Cancer Resistance
Osteopontin Induces Mitochondrial Biogenesis in Deadherent Cancer Cells
Cytostatic Persister Cancer Cells: Therapeutic Opportunities and Challenges
Risk Factors for Long-Term Arm Morbidities Following Breast Cancer Treatments: A Systematic Review
BCMA+ EV Levels Correlate With Myeloma Response to Belantamab-Mafodotin
Osteopontin Induces Mitochondrial Biogenesis in Deadherent Cancer Cells
Can Mechanisms of Hair Loss Shed Light on Cancer and Aging?
The Double-Edge Sword of CRISPR Application for In Vivo Studies
Targeting Ras with Protein Engineering
Genetic Predisposition to Early Breast Cancer in Kazakh Women
Predicting the Functions of Regulatory Genetic Variants Associated with Cancer
Immunotherapy Response in Primary vs Metastatic Pancreatic Cancer
The Obesity Paradox: Metformin for Diabetes and Lung Cancer?
C/EBPβ Helps MYB Maintain the Oncogenic Program of AML Cells
Combined Inhibition of SHP2 and Mutated RTKs Prevent Adaptive Resistance in Leukemia
The Role of HER2 Mutant Alleles in Breast Cancer
p53’s Protective Role in Extrahepatic Biliary Precancerous Lesions
FAAH Inhibition Ameliorates Murine Breast Cancer
Neutrophil PAD4 in Cancer, Beyond Promoting NETosis
Genetic Modifiers of p53 and Their Potential in Breast Cancer Therapies
Apoptotic Cells May Drive Cell Death in Hair Follicles During Regression Cycle
How a Metabolic Enzyme Can Trigger Cell Death in Liver Cancer Cells
GLS2 Shapes Ferroptosis in Hepatocellular Carcinoma
The Nuclear Envelope and Breast Cancer Metastasis
GBP3-STING Interaction in Glioblastoma Coordinates Poor Response to Temozolomide
HER3: A Vital Target in Cancer Treatment
Suppression of Cancer Stemness & Drug Resistance via BRAF/EGFR/MEK Inhibition in Colorectal Cancer
STAT3 as a Target in H3K27M-mutant DMGs
Blog: Genetic Insights into Early Breast Cancer in Kazakhstan
UGDH in Clinical Oncology and Cancer Biology
An Ancient Anti-cancer Mechanism: DISE
Reassessing COVID-19 Precautions in 2023
Four Novel Receptors May Link Endometrial Cancer to PCOS
Blog: Targeting Fatty Acid Binding Proteins in Multiple Myeloma
DPP4 Inhibitors for Target Therapy Resistance in Renal Cell Carcinoma
Real-Time Live Tissue Sensitivity Assay for Pancreatic Adenocarcinoma
Systemic Treatment for Brain Metastasis in HER2-Positive Advanced Breast Cancer
Updates: MET Targeted Therapy for EXON 14 Mutations in Lung Cancer
Blog: Predicting Functions of Cancer-Associated Genetic Variants
Subpopulations of AIB1-Expressing Breast Cancer Cells Enable Invasion and Metastasis
Validation of a Comprehensive Genomic Profiling Assay: NeXT Dx™